Our Global Voices Posts

Proud to Protect Burkinabè from Meningitis

Posted on by By Isaïe Medah, MD, MSc

Isaïe Medah, MD, MSc, is a physician and director general of public health in Burkina Faso.
Dr. Isaïe Medah, Director General of Public Health, Burkina Faso

Isaïe Medah, MD, MSc, is a physician and director general of public health in Burkina Faso. Previously he was director of the country’s routine immunization program from 2015–2017 and director of disease control from 2011–2015.

Proud to Protect Burkinabè from Meningitis
By Isaïe Medah, MD, MSc

In a remote village of Burkina Faso, a woman around 60 years old lined up to get vaccinated with the meningococcal serogroup A conjugate vaccine (MenAfriVac™, MACV) during a recent vaccine campaign. The health workers explained that she could not get the vaccine because of her age. She said she would not go back home without receiving “le bon vaccin” because she wants to live longer in order to take care of her grandsons, whose mother passed away.

This story illustrates that demand for MACV is very high in Burkina Faso. For the people of Burkina Faso, meningitis is a very dangerous disease and everybody is afraid of it. So, MACV is seen as a fabulous medication to prevent serogroup A meningococcal disease. People of all ages seek to be vaccinated and we don’t have problems trying to encourage people to get the vaccine. Burkina Faso was the most affected country in sub-Saharan Africa in terms of meningitis disease and death, and experienced numerous severe meningitis epidemics in the past four decades. Sadly, meningitis has touched almost every family in Burkina Faso.

Public Health in Practice

People line up to get MACV during the first mass vaccination campaign in Burkina Faso in 2010.
People line up to get MACV during the first mass vaccination campaign in Burkina Faso in 2010.

As a public health scholar, a former director for disease control, and the current director general of public health, my role is to design and coordinate the implementation of a preparedness and response plan to prevent outbreaks. I am also responsible for effectively managing the response when an outbreak does occur. This includes implementing a meningitis vaccination program, establishing a strong surveillance system, and building capacity and social mobilization. My role is also to coordinate partners’ interventions within Burkina Faso.

Initially, Burkina Faso held a successful mass vaccination campaign in 2010 targeted to people under 30 years old. Children born since the 2010 campaign were not protected, so in 2016 we decided to add MACV to our routine childhood vaccination program, and conduct a second catch-up vaccination campaign targeting children younger than 5 years old.

During this campaign, I spent time in the field meeting with the community. I recall one encounter with a 70-year-old man who told me that it is better to vaccinate old people first so that they can take care of their sick children. For him, vaccinating children was not a good strategy because children cannot take care of their ill parents. If the parents die, it leaves the children suffering. For him, “le bon vaccin” can help old people live longer and healthier lives. I understood this man’s concerns, and spent time explaining to him and others throughout the rest of the campaign why we were concentrating efforts on children. I believe that Burkina Faso has success with our vaccination campaigns because we always include communication in our planning. During visits in the field, we sensitize the community to the vaccination strategy and why certain ages are targeted. To the 70-year old man, I explained that these targeted public health measures can also help to prevent meningitis in the general population.

Reaching the People of Burkina Faso

A child lines up to get her routine MACV vaccination in Burkina Faso in 2017. © Evelyn Hockstein/CDC Foundation
A child lines up to get her routine MACV vaccination in Burkina Faso in 2017. © Evelyn Hockstein/CDC Foundation

When we do need to get the message out about vaccination, we use various communication and administrative channels and social networks to interact with the Burkina Faso population. Local radio and TV stations, as well as community speakers, communicate about meningitis. Political leaders, religious leaders, and stars of all kinds contribute to sensitize people about meningitis. Social events (e.g., markets, funerals, weddings) are used to give information to people.

The media has reported rumors at times, which created panic within the community. As people are more likely to believe what they see in the news and on social media, as public health officials, we must react quickly to share the correct information and the actions we are taking to respond to public health emergencies.

Partners Work Together in Burkina Faso
Protecting people from meningitis has been stressful, but also exciting and rewarding. Personally, I work well under pressure. The fight against meningitis was one of the most thrilling positions I held within the Ministry of Health, because I was eager to succeed and make a difference.

It was collaborative, inclusive, multisectoral, and interdisciplinary work. I collaborated with partners such as CDC Atlanta, the World Health Organization (WHO), Agence de Médicine Préventive (AMP), and many other non-governmental organizations operating in the health sector. We shared experiences and learned from each other. Managing meetings with stakeholders was exciting during outbreaks, trying to mobilize partners to achieve targeted objectives.

I was fortunate to establish long, continuous, and fruitful collaborations, particularly with CDC Atlanta (the Meningitis and Vaccine Preventable Diseases Branch), WHO, and AMP. CDC Atlanta assisted the Ministry of Health to set up robust meningitis surveillance, the best within countries in the African meningitis belt. As part of MenAfriNet, several West Africa countries adopted the so-called “Burkina Faso model” of case-based meningitis surveillance. CDC Atlanta has strengthened lab capacities, and helped train hundreds of health workers on meningitis detection and response to meningitis outbreaks. I am most proud of Burkina Faso’s collaboration with CDC on evaluations of meningococcal serogroup A conjugate vaccine and other vaccines against bacterial meningitis. These collaborations have helped our country collect information to guide our vaccine programs and rid our country of serogroup A meningitis epidemics.

From Mass Campaigns to Routine Immunization

A childhood immunization record from Burkina Faso, 2017. © Evelyn Hockstein/CDC Foundation
A childhood immunization record from Burkina Faso, 2017. © Evelyn Hockstein/CDC Foundation

During the first MACV mass campaign, I was very happy to see people striving to get vaccinated. When done, the campaign covered 100% of the targeted age group. Since the campaign, we have reported only four cases of serogroup A meningococcal disease. Fortunately, last year I was in a position to coordinate MACV introduction into the routine immunization program, which began in March 2017. Burkina Faso became one of the first countries to add this vaccine as a routine childhood vaccination. The launch of the introduction was led by the Minister of Health himself and it was very successful. Since 2010, Burkina Faso has been free of meningitis epidemics due to serogroup A—I’m proud of that accomplishment. It makes me feel so happy when I’m in the field and see children getting routinely vaccinated against a disease that has affected so many Burkinabè in my lifetime.

Since MACV is well accepted by the population in Burkina Faso, the Ministry of Health coupled a second dose of measles/rubella vaccine (MR2) administration with MACV. The goal is to boost MR2 uptake for children 15 through 18 months old, which is usually low. With the support of MenAfriNet (CDC Atlanta), we are currently conducting a survey on the impact of the introduction of MACV on MR2 coverage. We hope to have preliminary results of this study in mid-2018.

Moving Forward
The implementation of MACV has been a great success for Burkina Faso that should be built on. Our country still experiences significant meningitis disease and epidemics due to other pathogens. I believe we should continue developing new effective meningitis vaccines to defeat the remaining causes of epidemic meningitis. It is my hope that someday we will achieve the dream of a meningitis-free Africa.



Posted on by By Isaïe Medah, MD, MScTags , , , , ,

Message from Hank Tomlinson, PhD, Acting Director of CDC’s Division of Global HIV & TB.

CDC's innovative efforts to find, cure, and prevent TB are creating a safer America and a safer world.

“We are at a key moment in the global fight against tuberculosis. Tremendous progress has been made and, yet, this preventable, curable infection still claims more lives than any other infectious disease or epidemic. As leaders come together on World TB Day and again at the United Nations High Level Meeting on TB in September, Read More >

Posted on by Dr. Hank Tomlinson

Global Health Security Agenda Programs Protect Americans from Infectious Disease Threats

Today’s world of increasing interconnectivity and mobility accelerates the shared global risk to human health and well-being. The United States cannot effectively protect the health of its citizens without addressing infectious disease threats around the world. A pathogen that begins in a remote town can reach major cities on all six continents in 36 hours[1]. Read More >

Posted on by Anne Schuchat, MD (RADM, USPHS)

World Birth Defects Day 2018 Raises Global Awareness of Birth Defects

Every year, millions of babies around the world are born with a serious birth defect. In many countries, birth defects are one of the leading causes of death in babies and young children. Babies who survive and live with these conditions are at an increased risk for long-term disabilities and other health problems. The fourth Read More >

Posted on by Margaret A. Honein, Ph.D, M.P.H., Acting Director, Division of Congenital and Developmental Disorders, National Center on Birth Defects and Developmental DisabilitiesTags ,

Continuing the Fight Against Zika

Zika virus continues to spread in many countries and territories around the globe. Because there is no vaccine or medicine for Zika, the virus and its associated health outcomes will remain a significant and enduring public health challenge. The Danger from Zika Although many people infected with Zika experience mild or no symptoms, infection during Read More >

Posted on by Olga L. Henao, MPH, PhD, Epidemiologist2 CommentsTags , , , ,

IMPACT Program in Kenya: A Fellow’s Experience

Oren (right) with some of his colleagues Dr. Vincent Yator (center) and Athanasio Omondi (left) engage with a International Union Against Tuberculosis and Lung Disease facilitator, Dr. Gihan El-Nehas (standing) during a group session.

Many doctors and other health workers in my country have limited background or training in leadership and management, yet they often find themselves in leadership positions. This was my case when I was appointed Sub-County Medical Officer in February 2014. Starting out was no easy task, considering I was more used to clinical work. Here, Read More >

Posted on by Dr. Oren Nyambane Ombiro4 CommentsTags , , ,

Creating Strength in Numbers to End Violence Against Women & Girls

Dr. Daniela Ligiero

The 16 Days of Activism Against Gender-Based Violence campaign falls every year between the International Day for the Elimination of Violence against Women on November 25th, and Human Rights Day on December 10th. It is a time to raise awareness and galvanize global support and action to end violence against women and girls around the Read More >

Posted on by Dr. Daniela Ligiero, Executive Director and CEO, Together for GirlsTags ,

Rubella and CRS Elimination: A Race Worth Winning

AEFI management kit

AEFI Management Kit. Photo credit: Rania Tohme/CDC More than 100,000 children worldwide are born with congenital rubella syndrome (CRS) every year to mothers infected with the rubella virus. Sadly, these children will suffer a lifetime because of birth defects such as blindness, deafness, and heart disease, even though a cost-effective vaccine is widely available to Read More >

Posted on by Susan Reef, MD, MPH, Medical Epidemiologist and Rubella Team Lead, Global Immunization Division & Gavin Grant, MD, MPH, Medical Epidemiologist, Global Immunization DivisionTags , , ,

Everyone Needs Somewhere to Go: World Toilet Day

Charcoal briquettes manufactured from human waste in East Africa

Charcoal briquettes manufactured from human waste in East Africa (Photo courtesy of Eric Mintz, CDC) We use toilets every day – at home, school, and work – yet 40% of the world’s population does not have this luxury.  Clean and safe toilets are more than just a place to use the restroom.  They are essential Read More >

Posted on by Madison Walter, MPH, CHESTags ,

Overcoming obstacles to polio eradication in Pakistan

Picture of worker distributing polio advocacy items to children.

Originally published on October 5, 2017 on Rotary Voices “Coming together is a beginning. Keeping together is progress. Working together is success.” Henry Ford When I first joined Pakistan’s PolioPlus Committee (PNPPC) as a manager close to eight years ago, polio eradication seemed within our reach. I used the opportunity to study poliomyelitis beyond just Read More >

Posted on by Alina A. Visram, manager, Pakistan National PolioPlus CommitteeTags ,